Article Details

Inflammatory bowel disease: treatment and management - The Pharmaceutical Journal

Retrieved on: 2021-10-26 15:35:20

Tags for this article:

Click the tags to see associated articles and topics

Inflammatory bowel disease: treatment and management - The Pharmaceutical Journal. View article details on hiswai:

Excerpt

Monoclonal antibodies infliximab and adalimumab (pictured) are licensed for both ulcerative colitis and Crohn's disease with comparable efficacy.

Article found on: pharmaceutical-journal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up